Spironolactone for Heart Failure

Spironolactone, an aldosterone receptor antagonist, has been FDA-approved for many years for treatment of edema, hypertension and primary hyperaldosteronism. Recently, it was reported to improve morbidity and mortality in patients with severe heart failure....

Cannot Access - We are sorry, but you cannot access the requested article.